Brain 5-lipoxygenase over-expression worsens memory, synaptic integrity, and tau pathology in the P301S mice.

about

Brain 5-lipoxygenase over-expression worsens memory, synaptic integrity, and tau pathology in the P301S mice.

Item

http://www.wikidata.org/entity/Q47438369

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Brain 5-lipoxygenase over-expr ...... u pathology in the P301S mice.

@en

Brain 5-lipoxygenase over-expr ...... u pathology in the P301S mice.

@nl

type

Item

label

Brain 5-lipoxygenase over-expr ...... u pathology in the P301S mice.

@en

Brain 5-lipoxygenase over-expr ...... u pathology in the P301S mice.

@nl

prefLabel

Brain 5-lipoxygenase over-expr ...... u pathology in the P301S mice.

@en

Brain 5-lipoxygenase over-expr ...... u pathology in the P301S mice.

@nl

P1476

Brain 5-lipoxygenase over-expr ...... u pathology in the P301S mice.

@en

P2093

Alana N Vagnozzi

http://www.w3.org/2001/XMLSchema#string

Domenico Praticò

http://www.w3.org/2001/XMLSchema#string

Phillip F Giannopoulos

http://www.w3.org/2001/XMLSchema#string

P2860

Behavioral assays with mouse models of Alzheimer's disease: practical considerations and guidelines.

Progressive Supranuclear Palsy and Corticobasal Degeneration: Pathophysiology and Treatment Options

Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model

Gene knockout of 5-lipoxygenase rescues synaptic dysfunction and improves memory in the triple-transgenic model of Alzheimer's disease.

Putative role of neuronal 5-lipoxygenase in an aging brain.

Zileuton restores memory impairments and reverses amyloid and tau pathology in aged Alzheimer's disease mice

Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration.

Absence of ALOX5 gene prevents stress-induced memory deficits, synaptic dysfunction and tauopathy in a mouse model of Alzheimer's disease.

5-lipoxygenase as an endogenous modulator of amyloid β formation in vivo.

Pharmacologic blockade of 5-lipoxygenase improves the amyloidotic phenotype of an Alzheimer's disease transgenic mouse model involvement of γ-secretase

P31

scholarly article

P356

10.1111/ACEL.12695

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29106033

http://www.w3.org/2001/XMLSchema#string

P932

5771392

http://www.w3.org/2001/XMLSchema#string